These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36980587)

  • 1. Differential Spatial Gene and Protein Expression Associated with Recurrence Following Chemoradiation for Localized Anal Squamous Cell Cancer.
    Hernandez S; Das P; Holliday EB; Shen L; Lu W; Johnson B; Messick CA; Taniguchi CM; Skibber J; Ludmir EB; You YN; Smith GL; Bednarski B; Kostousov L; Koay EJ; Minsky BD; Tillman M; Portier S; Eng C; Koong AC; Chang GJ; Foo WC; Wang J; Soto LS; Morris VK
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA-seq analysis identifies transcriptomic profiles associated with anal cancer recurrence among people living with HIV.
    Ye Y; Maroney KJ; Wiener HW; Mamaeva OA; Junkins AD; Burkholder GA; Sudenga SL; Khushman M; Al Diffalha S; Bansal A; Shrestha S
    Ann Med; 2023 Dec; 55(1):2199366. PubMed ID: 37177979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPV virus and biomarkers of resistance to chemoradiation in circulating tumor cells from patients with squamous cell carcinoma of the anus.
    Ruano APC; de Jesus Ferreira Costa D; Braun AC; Torres JA; Barbosa PHP; Abdallah EA; Barberan C; Souza E Silva V; Bovolim G; Buim MEC; da Silva Alves V; Riechelmann RP; Chinen LTD
    Pathol Res Pract; 2023 Mar; 243():154327. PubMed ID: 36731178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Genomic Profiling of Metastatic Squamous Cell Carcinoma of the Anal Canal.
    Morris V; Rao X; Pickering C; Foo WC; Rashid A; Eterovic K; Kim T; Chen K; Wang J; Shaw K; Eng C
    Mol Cancer Res; 2017 Nov; 15(11):1542-1550. PubMed ID: 28784613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiome Dynamics During Chemoradiation Therapy for Anal Cancer.
    Lin D; El Alam MB; Jaoude JA; Kouzy R; Phan JL; Elnaggar JH; Resendiz B; Medrano AYD; Lynn EJ; Nguyen ND; Noticewala SS; Mathew GG; Holliday EB; Minsky BD; Das P; Morris VK; Eng C; Mezzari MP; Petrosino JF; Ajami NJ; Klopp AH; Taniguchi CM; Colbert LE
    Int J Radiat Oncol Biol Phys; 2022 Aug; 113(5):974-984. PubMed ID: 35513187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers in Anal Cancer: Current Status in Diagnosis, Disease Progression and Therapeutic Strategies.
    Mathias-Machado MC; Peixoto RD; Moniz CMV; Jácome AA
    Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary surgery with or without postoperative radiotherapy in early stage squamous cell carcinoma in the anal canal and anal margin.
    Leon O; Hagberg O; Johnsson A
    Acta Oncol; 2018 Sep; 57(9):1209-1215. PubMed ID: 29490558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of squamous cell carcinoma of the anal canal.
    Armstrong SA; Malley R; Wang H; Lenz HJ; Arguello D; El-Deiry WS; Xiu J; Gatalica Z; Hwang JJ; Philip PA; Shields AF; Marshall JL; Salem ME; Weinberg BA
    J Gastrointest Oncol; 2021 Oct; 12(5):2423-2437. PubMed ID: 34790403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compartmentalized spatial profiling of the tumor microenvironment in head and neck squamous cell carcinoma identifies immune checkpoint molecules and tumor necrosis factor receptor superfamily members as biomarkers of response to immunotherapy.
    Sadeghirad H; Liu N; Monkman J; Ma N; Cheikh BB; Jhaveri N; Tan CW; Warkiani ME; Adams MN; Nguyen Q; Ladwa R; Braubach O; O'Byrne K; Davis M; Hughes BGM; Kulasinghe A
    Front Immunol; 2023; 14():1135489. PubMed ID: 37153589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docetaxel, Cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: a phase II study of French interdisciplinary GERCOR and FFCD groups (Epitopes-HPV02 study).
    Kim S; Jary M; André T; Vendrely V; Buecher B; François E; Bidard FC; Dumont S; Samalin E; Peiffert D; Pernot S; Baba-Hamed N; El Hajbi F; Bouché O; Desrame J; Parzy A; Zoubir M; Louvet C; Bachet JB; Nguyen T; Abdelghani MB; Smith D; De La Fouchardière C; Aparicio T; Bennouna J; Gornet JM; Jacquin M; Bonnetain F; Borg C
    BMC Cancer; 2017 Aug; 17(1):574. PubMed ID: 28841909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival following salvage abdominoperineal resection for persistent and recurrent squamous cell carcinoma of the anus: do these disease categories affect survival?
    Severino NP; Chadi SA; Rosen L; Coiro S; Choman E; Berho M; Wexner SD
    Colorectal Dis; 2016 Oct; 18(10):959-966. PubMed ID: 26850085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can Anal Cytology Be a Tool in Following Patients Treated for Squamous Cell Carcinoma of the Anus?
    Brasseur B; Subillaga O; Vrees M; Klipfel A; Roth L; Schechter S
    Am Surg; 2022 Jul; 88(7):1621-1625. PubMed ID: 35258352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic and Predictive Markers for Patients With Anal Cancer.
    Holliday EB; Peddireddy A; Morris VK
    J Natl Compr Canc Netw; 2023 Jun; 21(6):678-684. PubMed ID: 37308122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of HIV Status With Local Immune Response to Anal Squamous Cell Carcinoma: Implications for Immunotherapy.
    Yanik EL; Kaunitz GJ; Cottrell TR; Succaria F; McMiller TL; Ascierto ML; Esandrio J; Xu H; Ogurtsova A; Cornish T; Lipson EJ; Topalian SL; Engels EA; Taube JM
    JAMA Oncol; 2017 Jul; 3(7):974-978. PubMed ID: 28334399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic Metastasectomy in Squamous Cell Carcinoma of the Anal Canal: A Case Series of a Curative Approach.
    Rogers JE; Sirisaengtaksin A; Leung M; Morris VK; Xiao L; Huey R; Wolff R; Eng C; Vauthey JN; Tzeng CD; Johnson B
    Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Squamous cell anal carcinoma. What's next ?].
    Kim S; Spehner L; Cabel L; Bidard FC; Borg C
    Bull Cancer; 2021 Jan; 108(1):80-89. PubMed ID: 33423780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Premalignant lesions of the anal canal and squamous cell carcinoma of the anal canal.
    Poggio JL
    Clin Colon Rectal Surg; 2011 Sep; 24(3):177-92. PubMed ID: 22942800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum squamous cell carcinoma antigen as an early indicator of response during therapy of cervical cancer.
    Markovina S; Wang S; Henke LE; Luke CJ; Pak SC; DeWees T; Pfeifer JD; Schwarz JK; Liu W; Chen S; Mutch D; Wang X; Powell MA; Siegel BA; Dehdashti F; Silverman GA; Grigsby PW
    Br J Cancer; 2018 Jan; 118(1):72-78. PubMed ID: 29112685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of squamous cell carcinoma antigen 1 expression in oral squamous cell carcinoma (tumor cells and peritumoral T-lymphocytes) and verrucous carcinoma and comparison with normal oral mucosa.
    Derakhshan S; Poosti A; Razavi AE; Moosavi MA; Mahdavi N; Naieni FB; Hesari KK; Rahpeima A
    J Appl Oral Sci; 2021; 29():e20210374. PubMed ID: 34878006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SCCA, TSGF, and the Long Non-Coding RNA AC007271.3 are Effective Biomarkers for Diagnosing Oral Squamous Cell Carcinoma.
    Shao T; Huang J; Zheng Z; Wu Q; Liu T; Lv X
    Cell Physiol Biochem; 2018; 47(1):26-38. PubMed ID: 29763905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.